MongoDB Inc. diskutieren
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Barclays PLC from $458.00 to $290.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Loop Capital from $415.00 to $315.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) was upgraded by analysts at DA Davidson from a "hold" rating to a "strong-buy" rating.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Citigroup Inc. from $480.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $290.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Piper Sandler from $350.00 to $300.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Piper Sandler from $300.00 to $335.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Bank of America Co. from $300.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Morgan Stanley from $320.00 to $340.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Oppenheimer Holdings Inc. from $300.00 to $350.00. They now have an "outperform" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Truist Financial Co. from $300.00 to $320.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Stifel Nicolaus from $300.00 to $325.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Wells Fargo & Company from $300.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $350.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Needham & Company LLC from $290.00 to $335.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Sanford C. Bernstein from $358.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at DA Davidson from $265.00 to $330.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Citigroup Inc. from $350.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at DA Davidson from $330.00 to $340.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) was upgraded by analysts at Wedbush to a "strong-buy" rating.
Ratings data for MDB provided by MarketBeat
Neueste Beiträge
Canaccord_Genuity_Gr in Ultragenyx Pharmaceutical Inc. diskutieren